Trump signed an executive order to lower US drug prices. This involves allowing states to negotiate overseas and streamlining the process. The order modifies the Inflation Reduction Act, aiming for fairer pricing between tablets and injectables. While it doesn't utilize 'most favored nation' status, it seeks to align prices with drug value, providing relief to many Americans.
